rs34759087

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_002292.4(LAMB2):​c.2959G>A​(p.Glu987Lys) variant causes a missense change. The variant allele was found at a frequency of 0.116 in 1,614,066 control chromosomes in the GnomAD database, including 12,496 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E987D) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.092 ( 935 hom., cov: 33)
Exomes 𝑓: 0.12 ( 11561 hom. )

Consequence

LAMB2
NM_002292.4 missense

Scores

6
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 4.06

Publications

40 publications found
Variant links:
Genes affected
LAMB2 (HGNC:6487): (laminin subunit beta 2) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 2. The beta 2 chain contains the 7 structural domains typical of beta chains of laminin, including the short alpha region. However, unlike beta 1 chain, beta 2 has a more restricted tissue distribution. It is enriched in the basement membrane of muscles at the neuromuscular junctions, kidney glomerulus and vascular smooth muscle. Transgenic mice in which the beta 2 chain gene was inactivated by homologous recombination, showed defects in the maturation of neuromuscular junctions and impairment of glomerular filtration. Alternative splicing involving a non consensus 5' splice site (gc) in the 5' UTR of this gene has been reported. It was suggested that inefficient splicing of this first intron, which does not change the protein sequence, results in a greater abundance of the unspliced form of the transcript than the spliced form. The full-length nature of the spliced transcript is not known. [provided by RefSeq, Aug 2011]
LAMB2 Gene-Disease associations (from GenCC):
  • Pierson syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, PanelApp Australia, Orphanet
  • LAMB2-related infantile-onset nephrotic syndrome
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.003787607).
BP6
Variant 3-49124851-C-T is Benign according to our data. Variant chr3-49124851-C-T is described in ClinVar as Benign. ClinVar VariationId is 258606.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMB2NM_002292.4 linkc.2959G>A p.Glu987Lys missense_variant Exon 21 of 32 ENST00000305544.9 NP_002283.3 P55268
LAMB2XM_005265127.5 linkc.2959G>A p.Glu987Lys missense_variant Exon 22 of 33 XP_005265184.1 P55268

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMB2ENST00000305544.9 linkc.2959G>A p.Glu987Lys missense_variant Exon 21 of 32 1 NM_002292.4 ENSP00000307156.4 P55268

Frequencies

GnomAD3 genomes
AF:
0.0921
AC:
14015
AN:
152146
Hom.:
934
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0196
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0668
Gnomad ASJ
AF:
0.234
Gnomad EAS
AF:
0.00308
Gnomad SAS
AF:
0.144
Gnomad FIN
AF:
0.188
Gnomad MID
AF:
0.142
Gnomad NFE
AF:
0.124
Gnomad OTH
AF:
0.0794
GnomAD2 exomes
AF:
0.109
AC:
27313
AN:
251384
AF XY:
0.115
show subpopulations
Gnomad AFR exome
AF:
0.0178
Gnomad AMR exome
AF:
0.0511
Gnomad ASJ exome
AF:
0.235
Gnomad EAS exome
AF:
0.00125
Gnomad FIN exome
AF:
0.181
Gnomad NFE exome
AF:
0.119
Gnomad OTH exome
AF:
0.119
GnomAD4 exome
AF:
0.118
AC:
172908
AN:
1461802
Hom.:
11561
Cov.:
36
AF XY:
0.120
AC XY:
87413
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.0180
AC:
602
AN:
33480
American (AMR)
AF:
0.0518
AC:
2316
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
6096
AN:
26136
East Asian (EAS)
AF:
0.00113
AC:
45
AN:
39700
South Asian (SAS)
AF:
0.158
AC:
13609
AN:
86256
European-Finnish (FIN)
AF:
0.170
AC:
9055
AN:
53350
Middle Eastern (MID)
AF:
0.162
AC:
935
AN:
5768
European-Non Finnish (NFE)
AF:
0.120
AC:
132914
AN:
1111994
Other (OTH)
AF:
0.121
AC:
7336
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
10393
20785
31178
41570
51963
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4750
9500
14250
19000
23750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0920
AC:
14013
AN:
152264
Hom.:
935
Cov.:
33
AF XY:
0.0954
AC XY:
7101
AN XY:
74442
show subpopulations
African (AFR)
AF:
0.0196
AC:
815
AN:
41558
American (AMR)
AF:
0.0667
AC:
1021
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.234
AC:
812
AN:
3472
East Asian (EAS)
AF:
0.00309
AC:
16
AN:
5178
South Asian (SAS)
AF:
0.145
AC:
700
AN:
4828
European-Finnish (FIN)
AF:
0.188
AC:
1990
AN:
10604
Middle Eastern (MID)
AF:
0.139
AC:
41
AN:
294
European-Non Finnish (NFE)
AF:
0.124
AC:
8399
AN:
68000
Other (OTH)
AF:
0.0791
AC:
167
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
649
1297
1946
2594
3243
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.111
Hom.:
3305
Bravo
AF:
0.0761
TwinsUK
AF:
0.119
AC:
442
ALSPAC
AF:
0.118
AC:
456
ESP6500AA
AF:
0.0207
AC:
91
ESP6500EA
AF:
0.132
AC:
1139
ExAC
AF:
0.106
AC:
12816
Asia WGS
AF:
0.0620
AC:
221
AN:
3478
EpiCase
AF:
0.124
EpiControl
AF:
0.116

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 01, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Pierson syndrome;C3280113:LAMB2-related infantile-onset nephrotic syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

LAMB2-related infantile-onset nephrotic syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Pierson syndrome Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.087
BayesDel_addAF
Benign
-0.55
T
BayesDel_noAF
Benign
-0.44
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.075
T;T
Eigen
Benign
0.17
Eigen_PC
Uncertain
0.27
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.88
.;D
MetaRNN
Benign
0.0038
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.3
L;L
PhyloP100
4.1
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-1.5
N;N
REVEL
Benign
0.083
Sift
Uncertain
0.024
D;D
Sift4G
Uncertain
0.049
D;D
Polyphen
0.70
P;P
Vest4
0.18
MPC
0.19
ClinPred
0.0067
T
GERP RS
4.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.21
gMVP
0.35
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs34759087; hg19: chr3-49162284; COSMIC: COSV107369083; COSMIC: COSV107369083; API